01.09.2008 | Case Reports
Bilateral inflammatory metachronic ERBB2 (HER2/neu)-positive breast carcinoma: prolonged survival with combined chemotherapy and trastuzumab
Erschienen in: Clinical and Translational Oncology | Ausgabe 9/2008
Einloggen, um Zugang zu erhalten